Biotechnology company Recursion Pharmaceuticals Inc. $RXRX, based in Salt Lake City, is venturing into a groundbreaking initiative that could reshape the pharmaceutical landscape. Leveraging artificial intelligence in drug development, Recursion is contemplating a subscription model similar to Amazon Prime for the sale of its medication. This strategy has the potential to significantly impact the pharmaceutical industry and the distribution methods of medical products.